Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 444, 256-257 (16 November 2006) | doi:10.1038/444256a; Published online 15 November 2006
Open Innovation Challenges
-
Optimizing Sub-cellular Localization Tags
The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
- More Challenges
- Powered by:
nature jobs
Faculty Position - Center for Viral Oncology
- University of Kansas Medical Center
- Kansas City, KS
Postdoctoral Fellow (Genetics / Genomics of Brain Tumors)
- M.D. Anderson Cancer Center
- Houston, Texas, USA
The chips are down
Abstract
Geneticists' desire to track the roots of complex diseases has shaken up the market for gene chips. Meredith Wadman reports on two firms jostling for position in a business potentially worth US$500 million.
Wall Street analyst Elise Wang began her coverage of the Goliath of gene-chip makers last month with an unequivocal recommendation: sell.Her advice came despite the fact that shares in Affymetrix, the company based in Santa Clara, California, whose scientists invented the gene chip 17 years ago, are already trading down by almost 50% from where they were a year ago (see graph).
To read this story in full you will need to login or make a payment (see right).
